Acura Pharmaceuticals Inc.
616 N. North Court
Suite 120
Palatine,
IL 60067
United States - Map
Phone: 847-705-7709
Fax: 847-705-5399
Web Site: http://www.acurapharm.com
| Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of Aversion Technology related product candidates. The companys Aversion Technology acts as a platform for developing multiple opioid analgesic products candidates containing codeine, propoxyphene, morphine, hydrocodone, oxycodone, tramadol, and various other opioid analgesics. Its opioid analgesic products are used to relieve pain, as well as to discourage common methods of pharmaceutical product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. The company has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize opioid analgesic products, including Acurox tablets, an orally administered immediate release tablet containing oxycodone HCl; Acuracet tablets containing oxycodone HCl/niacin/APAP; and Vycavert tablets containing hydrocodone bitartrate/niacin/APAP utilizing the Aversion Technology in the United States, Canada, and Mexico. Acura Pharmaceuticals, Inc. was founded in 1935 and is based in Palatine, Illinois. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Andrew D. Reddick , 56
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Peter A. Clemens , 56
Chief Financial Officer, Principal Accounting Officer, Sr. VP of Investor Relations and Sec. |
N/A
| N/A | Mr. Robert B. Jones , 50
Chief Operating Officer and Sr. VP |
$
342.00K | N/A | Mr. Robert A. Seiser , 45
VP, Treasurer and Corp. Controller |
N/A
| N/A | Dr. Ron J. Spivey Ph.D., 62
Sr. Scientific Advisor |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.14% Nasdaq 0.00%
Profile
